Nanosilver: An Old Antibacterial Agent with Great Promise in the Fight against Antibiotic Resistance
Antibiotics · 31.07.2023 · 12 (8) · 1264
DOI: 10.3390/antibiotics12081264 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 31.07.2023. Verfasst von Kyra G Kaiser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Environmental Sciences, Texas A&M University Corpus Christi, 6300 Ocean Drive, Corpus Christi, TX 78412, USA. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 349 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, SC.
Abstract (Originalsprache)
Antibiotic resistance in bacteria is a major problem worldwide that costs 55 billion USD annually for extended hospitalization, resource utilization, and additional treatment expenditures in the United States. This review examines the roles and forms of silver (e.g., bulk Ag, silver salts (AgNO3), and colloidal Ag) from antiquity to the present, and its eventual incorporation as silver nanoparticles (AgNPs) in numerous antibacterial consumer products and biomedical applications. The AgNP fabrication methods, physicochemical properties, and antibacterial mechanisms in Gram-positive and Gram-negative bacterial models are covered. The emphasis is on the problematic ESKAPE pathogens and the antibiotic-resistant pathogens of the greatest human health concern according to the World Health Organization. This review delineates the differences between each bacterial model, the role of the physicochemical properties of AgNPs in the interaction with pathogens, and the subsequent damage of AgNPs and Ag+ released by AgNPs on structural cellular components. In closing, the processes of antibiotic resistance attainment and how novel AgNP–antibiotic conjugates may synergistically reduce the growth of antibiotic-resistant pathogens are presented in light of promising examples, where antibiotic efficacy alone is decreased.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical and Environmental Sciences, Texas A&M University Corpus Christi, 6300 Ocean Drive, Corpus Christi, TX 78412, USA.
- Department of Life Sciences, Texas A&M University Corpus Christi, 6300 Ocean Drive, Corpus Christi, TX 78412, USA.
- Department of Chemistry, Physics, Geology and the Environment, Winthrop University, 701 Oakland Avenue, Rock Hill, SC 29733, USA.
- Department of Biology, Winthrop University, 701 Oakland Avenue, Rock Hill, SC 29733, USA.
ORCID-Profile: Victoria J Frost, Gregory W Buck, Ioana E Pavel
Förderung
- NIGMS NIH HHS
- National Science Foundation
- SC
- Texas A&M University Corpus Christi, Texas
- Winthrop University, South Carolina
Zitieren
APA
Kaiser, K. G., Delattre, V., Frost, V. J., Buck, G. W., Phu, J. V., Fernandez, T. G., & Pavel, I. E. (2023). Nanosilver: An Old Antibacterial Agent with Great Promise in the Fight against Antibiotic Resistance. Antibiotics, 12(8), 1264. https://doi.org/10.3390/antibiotics12081264
Vancouver
Kaiser KG, Delattre V, Frost VJ, Buck GW, Phu JV, Fernandez TG, et al. Nanosilver: An Old Antibacterial Agent with Great Promise in the Fight against Antibiotic Resistance. Antibiotics. 2023;12(8):1264. doi:10.3390/antibiotics12081264
BibTeX
@article{Kaiser2023,
author = {Kaiser, Kyra G and Delattre, Victoire and Frost, Victoria J and Buck, Gregory W and Phu, Julianne V and Fernandez, Timea G and Pavel, Ioana E},
title = {Nanosilver: An Old Antibacterial Agent with Great Promise in the Fight against Antibiotic Resistance},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {8},
pages = {1264},
doi = {10.3390/antibiotics12081264}
}
EUVIMED